MEG3 and osteosarcoma: Huang et al. designed and prepared c(RGDyK)-modified and maternally expressed gene 3 (MEG3)-loaded exosomes (cRGD-Exo-MEG3), which were efficiently delivered to osteosarcoma cells for anti-osteosarcoma roles in vitro and in vivo [187].